National Cancer Institute
31 Center Drive, Bethesda, Maryland 20814
The National Cancer Institute is not just a medical facility but also a useful resource for hospitals and mesothelioma cancer centers in the United States. Groundbreaking and translational research takes place at the National Cancer Institute that could lead to new treatment options for mesothelioma.
Pleural Mesothelioma and Peritoneal Mesothelioma
National Cancer Institute
31 Center Drive
Bethesda, MD 20814
Dr. Raffit Hassan
JUMP TO A TOPIC
More About Mesothelioma Treatment at the National Cancer Institute
The National Cancer Institute (NCI) is the United States federal government’s agency of cancer research and training. The NCI was established in 1937 as part of the National Institutes of Health, which is part of the Department of Health and Human Services. The National Institutes of Health Clinical Center is the largest hospital devoted 100% to medical research.
NCI’s primary mission is to conduct cancer research initiatives across different malignancies, including the rare and aggressive cancer known as mesothelioma. This spearheading of cancer research is collectively called the National Cancer Program, which is the largest funding platform for cancer research in the entire world. The data reaches cancer centers and doctors throughout the country to improve the clinical trials and studies conducted at different institutions.
Dr. Raffit Hassan is the Senior Investigator of Thoracic and Gastrointestinal Malignancies. He is in charge of all cancer research related to mesothelioma and helps improve detection of and treatment for mesothelioma.
The two types of mesothelioma are:
- Pleural mesothelioma, a thoracic cancer forming in the lining of the lungs
- Peritoneal mesothelioma, a gastrointestinal cancer forming in the lining of the abdominal cavity
Experienced Mesothelioma Specialists
- Dr. Raffit Hassan, Chief of Thoracic and Gastrointestinal Malignancies
- Dr. Chuong D. Hoang, investigator
Affiliations
- National Institutes of Health
- Department of Health and Human Services
Treatment Specialties
- Clinical trials and research
Get Connected to the National Cancer Institute
The National Cancer Institute (NCI) is the only government-funded hospital dedicated solely to clinical research for cancer. Mesothelioma is one cancer their research focuses on – mostly through clinical trials and testing. National Cancer Institute is a leading center for conducting clinical trials for this rare disease.
Why Choose NCI?
- Affiliation with and funding from the National Institutes of Health
- Ongoing clinical trials at the cancer center
- Collaboration with other cancer centers in the United States
Collaboration With Other Cancer Hospitals
NCI designates other cancer centers around the country for their treatment, patient care, and patient comfort. This designation is a badge of honor for cancer hospitals and proof of their high-quality medical care.
As of July 2024, the mesothelioma hospitals – or hospitals featuring at least one mesothelioma specialist – with an NCI designation as a leading center are:
- Baylor College of Medicine Dan L. Duncan Comprehensive Cancer Center (Houston, Texas)
- Brigham and Women’s Hospital Dana-Farber Cancer Institute (Boston, Massachusetts)
- Duke Cancer Institute (Durham, North Carolina)
- Fox Chase Cancer Center (Philadelphia, Pennsylvania)
- Icahn School of Medicine at Mount Sinai Tisch Cancer Institute (New York City)
- Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center (Baltimore, Maryland)
- Mayo Clinic (Rochester, Minnesota)
- Mayo Clinic (Phoenix, Arizona)
- Mayo Clinic (Jacksonville, Florida)
- Michigan University Medicine Rogel Cancer Institute (Ann Arbor)
- Memorial Sloan Kettering Cancer Center (New York City)
- Moffitt Cancer Center (Tampa, Florida)
- NYU Langone Health Laura and Isaac Perlmutter Cancer Center (New York City)
- Roswell Park Comprehensive Cancer Center (Buffalo, N.Y.)
- Rutgers Cancer Institute of New Jersey (New Brunswick)
- University of California Los Angeles Jonsson Comprehensive Cancer Center
- University of California San Diego Moores Comprehensive Cancer Center
- University of California San Francisco Helen Diller Comprehensive Cancer Center
- University of Chicago Comprehensive Cancer Center
- University of Hawaii Cancer Center (Honolulu)
- University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
- University of Miami Sylvester Comprehensive Cancer Center
- University of Pennsylvania Abramson Cancer Center (Philadelphia)
- University of Pittsburgh Medical Center Hillman Cancer Center
- University of Texas MD Anderson Cancer Center (Houston)
- Vanderbilt-Ingram Cancer Center (Nashville, Tennessee)
- Wake Forest Baptist Cancer Center (Winston-Salem, North Carolina)
Database of Mesothelioma Clinical Trials
If you’re looking to enroll in a clinical trial for mesothelioma, the National Cancer Institute is the place to start your search. NCI takes part in more than a dozen studies involving mesothelioma, some dedicated just to this disease. A few examples are immunotherapy trials, photodynamic therapy studies, and even a peritoneal mesothelioma trial using immunotherapy.
Linda P., who died in 2020 of mesothelioma, was able to extend her survival thanks to a clinical trial at NCI. She received immunotherapy plus an anti-mesothelin drug LMB-100. Her family credit the doctors and nurses at NCI for slowing the growth of tumors and giving Linda more time to spend with her family.
“She never had any more pain up until the day she died,” Laurie, her daughter, told Mesothelioma Guide. “The people at (NCI) were miracle-workers. We just loved everyone there.”
Linda’s story is an example of the power of the National Cancer Institute’s work for cancer patients, particularly those with rare diseases like mesothelioma.
Get Connected to NCI
Please reach out to our patient advocate team for help visiting the National Cancer Institute. Karen Ritter, our lead patient advocate, is a registered nurse and cancer survivor. She communicates with patients and their families about their options for treatment along with tips for going through the therapeutic process.
Email Nurse Karen at karen@mesotheliomaguide.com for help. She’d be happy to assist you in contacting NCI or giving you a list of the recruiting clinical trials happening right now.
Sources & Author
- National Cancer Institutes. National Institute of Health. Retrieved from: https://www.nih.gov/about-nih/what-we-do/nih-almanac/national-cancer-institute-nci. Accessed: 03/09/2022.
- Mesothelioma. National Cancer Institute. Retrieved from: https://ccr.cancer.gov/staff-directory/principal-investigators/disease-focuses/mesothelioma. Accessed: 05/17/2023.
- Find a Cancer Center. National Cancer Institute. Retrieved from: https://www.cancer.gov/research/infrastructure/cancer-centers/find. Accessed: 07/21/2024.
- Raffit Hassan, M.D. National Cancer Institute. Retrieved from: https://ccr.cancer.gov/staff-directory/raffit-hassan. Accessed: 05/17/2023.
AI Summary of National Cancer Institute
The National Cancer Institute (NCI), located in Bethesda, Maryland, is a leading organization dedicated to advancing cancer research and providing resources for patients and healthcare providers across the United States. It functions not only as a research facility but also as a vital support system for hospitals and specialized cancer centers, including those treating mesothelioma, a rare and aggressive form of cancer. The NCI conducts groundbreaking research that can lead to new treatment options and improved methods of detection for mesothelioma, offering hope to patients and families affected by this disease. Their focus is on understanding different types of mesothelioma, including pleural mesothelioma, which affects the lining of the lungs, and peritoneal mesothelioma, which occurs in the abdominal lining.
The NCI plays a central role in coordinating clinical trials, which are essential in testing new therapies and expanding treatment options. Experts such as Dr. Raffit Hassan, the senior investigator with specialized knowledge in thoracic and gastrointestinal cancers, lead efforts to improve detection and treatment strategies for mesothelioma. The institution’s research efforts are supported by partnerships with high-quality cancer centers across the country, many of which are designated as NCI-designated centers, recognized for their excellence in patient care and research. These partnerships help ensure that patients diagnosed with mesothelioma can access the most advanced treatments available.
For individuals seeking new treatment options or considering participation in clinical trials, the NCI provides a comprehensive database of ongoing studies, including innovative approaches such as immunotherapy and targeted drugs. These trials aim to improve survival rates and quality of life for patients diagnosed with mesothelioma. The NCI is committed to collaboration and innovation, working closely with other leading cancer centers to facilitate research and bring promising therapies from the laboratory to the clinic. Patients and families can connect with the NCI through a dedicated team that offers guidance and support, helping them navigate the complex process of treatment and clinical trial enrollment.
In summary, the NCI is a crucial institution in the fight against mesothelioma, conducting vital research to develop better treatments and offering resources for patients to explore their options. Its multidisciplinary approach, collaborative network, and focus on clinical trials provide hope and valuable opportunities for those facing this challenging cancer. Families and individuals confronted with mesothelioma are encouraged to learn more about the available options and to consider connecting with the NCI to access the latest innovations in cancer care and research.